Company
Company Overview
| Name of company | Axcelead Tokyo West Partners, Inc. |
| Foundation | April 1, 2024 |
| History | On April 1, 2024, Axcelead, Inc. and Teijin Limited established a joint venture company, Axcelead Tokyo West Partners, Inc. This new entity inherited certain functions related to drug discovery research, including technology, facilities, equipment, and personnel from Teijin Pharma Corporation through an absorption-type split scheme. It commenced an integrated drug discovery CRO (Contract Research Organization) business. |
| Office | 4-3-2 Asahigaoka, Hino-shi, Tokyo, 191-0065 |
| Employees | Approximately 120 |
| Business Description | Provision of advisory and contracted services related to drug discovery research |
| Fiscal Year End | March |
Directors and Officers
| Representative Director | Kengo Okada |
| Board Director | Hiroki Maekawa Junji Torigoe |
| Audit Committee Member | Fumiaki Masuko |
Access
4-3-2 Asahigaoka, Hino-shi, Tokyo, 191-0065
Google Map
Public Transportation
[JR] From the north exit of Toyoda Station on the JR Chuo Line, take the Keio Bus “Hirayama Industrial Park Loop” for about 5 minutes and get off at “Hirayama Industrial Park”
- Home
- Company